vs

Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

FVCBankcorp, Inc. is the larger business by last-quarter revenue ($16.9M vs $13.2M, roughly 1.3× TriSalus Life Sciences, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs 59.8%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-2.5M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 43.0%).

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

FVCB vs TLSI — Head-to-Head

Bigger by revenue
FVCB
FVCB
1.3× larger
FVCB
$16.9M
$13.2M
TLSI
Growing faster (revenue YoY)
FVCB
FVCB
+4317.7% gap
FVCB
4377.5%
59.8%
TLSI
More free cash flow
FVCB
FVCB
$26.3M more FCF
FVCB
$23.8M
$-2.5M
TLSI
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
43.0%
TLSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FVCB
FVCB
TLSI
TLSI
Revenue
$16.9M
$13.2M
Net Profit
$-9.8M
Gross Margin
86.7%
Operating Margin
43.7%
-24.8%
Net Margin
-73.9%
Revenue YoY
4377.5%
59.8%
Net Profit YoY
3.5%
EPS (diluted)
$0.31
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FVCB
FVCB
TLSI
TLSI
Q4 25
$16.9M
$13.2M
Q3 25
$416.0K
$11.6M
Q2 25
$15.8M
$11.2M
Q1 25
$382.0K
$9.2M
Q4 24
$378.0K
$8.3M
Q3 24
$412.0K
$7.3M
Q2 24
$415.0K
$7.4M
Q1 24
$359.0K
$6.5M
Net Profit
FVCB
FVCB
TLSI
TLSI
Q4 25
$-9.8M
Q3 25
$5.6M
$-10.8M
Q2 25
$5.7M
$-8.3M
Q1 25
$5.2M
$-10.4M
Q4 24
$-10.1M
Q3 24
$4.7M
$-2.4M
Q2 24
$4.2M
$-4.3M
Q1 24
$1.3M
$-13.2M
Gross Margin
FVCB
FVCB
TLSI
TLSI
Q4 25
86.7%
Q3 25
83.5%
Q2 25
83.9%
Q1 25
83.7%
Q4 24
85.3%
Q3 24
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
FVCB
FVCB
TLSI
TLSI
Q4 25
43.7%
-24.8%
Q3 25
-77.9%
Q2 25
45.9%
-65.4%
Q1 25
-79.9%
Q4 24
-91.8%
Q3 24
-118.9%
Q2 24
-111.0%
Q1 24
-180.8%
Net Margin
FVCB
FVCB
TLSI
TLSI
Q4 25
-73.9%
Q3 25
1341.1%
-93.5%
Q2 25
36.0%
-73.9%
Q1 25
1352.1%
-113.2%
Q4 24
-122.4%
Q3 24
1133.3%
-32.6%
Q2 24
1001.2%
-58.8%
Q1 24
373.3%
-204.5%
EPS (diluted)
FVCB
FVCB
TLSI
TLSI
Q4 25
$0.31
$-0.22
Q3 25
$0.31
$-0.96
Q2 25
$0.31
$-0.27
Q1 25
$0.28
$-0.39
Q4 24
$0.27
$-0.38
Q3 24
$0.25
$-0.12
Q2 24
$0.23
$-0.21
Q1 24
$0.07
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FVCB
FVCB
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$20.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$253.6M
$-33.9M
Total Assets
$2.3B
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FVCB
FVCB
TLSI
TLSI
Q4 25
$20.4M
Q3 25
$22.7M
Q2 25
$26.5M
Q1 25
$13.0M
Q4 24
$8.5M
Q3 24
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Stockholders' Equity
FVCB
FVCB
TLSI
TLSI
Q4 25
$253.6M
$-33.9M
Q3 25
$249.8M
$-26.7M
Q2 25
$243.2M
$-19.4M
Q1 25
$242.3M
$-34.4M
Q4 24
$235.4M
$-25.9M
Q3 24
$230.8M
$-20.4M
Q2 24
$226.5M
$-25.3M
Q1 24
$220.7M
$-36.0M
Total Assets
FVCB
FVCB
TLSI
TLSI
Q4 25
$2.3B
$35.3M
Q3 25
$2.3B
$36.5M
Q2 25
$2.2B
$41.3M
Q1 25
$2.2B
$28.6M
Q4 24
$2.2B
$24.0M
Q3 24
$2.3B
$27.5M
Q2 24
$2.3B
$32.4M
Q1 24
$2.2B
$17.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FVCB
FVCB
TLSI
TLSI
Operating Cash FlowLast quarter
$23.9M
$-2.5M
Free Cash FlowOCF − Capex
$23.8M
$-2.5M
FCF MarginFCF / Revenue
140.7%
-19.1%
Capex IntensityCapex / Revenue
0.3%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.0M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FVCB
FVCB
TLSI
TLSI
Q4 25
$23.9M
$-2.5M
Q3 25
$7.6M
$-3.7M
Q2 25
$3.3M
$-7.3M
Q1 25
$5.4M
$-4.5M
Q4 24
$18.2M
$-5.7M
Q3 24
$4.7M
$-10.8M
Q2 24
$1.6M
$-13.4M
Q1 24
$7.2M
$-10.9M
Free Cash Flow
FVCB
FVCB
TLSI
TLSI
Q4 25
$23.8M
$-2.5M
Q3 25
$7.6M
$-3.9M
Q2 25
$3.3M
$-7.4M
Q1 25
$5.4M
$-5.3M
Q4 24
$18.1M
$-5.8M
Q3 24
$4.6M
$-11.0M
Q2 24
$1.5M
$-13.5M
Q1 24
$7.1M
$-10.9M
FCF Margin
FVCB
FVCB
TLSI
TLSI
Q4 25
140.7%
-19.1%
Q3 25
1818.0%
-33.9%
Q2 25
20.8%
-66.1%
Q1 25
1413.6%
-57.3%
Q4 24
4786.0%
-69.7%
Q3 24
1121.8%
-149.9%
Q2 24
361.2%
-183.1%
Q1 24
1988.3%
-169.3%
Capex Intensity
FVCB
FVCB
TLSI
TLSI
Q4 25
0.3%
0.3%
Q3 25
0.2%
1.9%
Q2 25
0.1%
0.8%
Q1 25
4.2%
8.2%
Q4 24
37.3%
0.6%
Q3 24
14.1%
2.3%
Q2 24
12.8%
0.8%
Q1 24
3.9%
1.0%
Cash Conversion
FVCB
FVCB
TLSI
TLSI
Q4 25
Q3 25
1.36×
Q2 25
0.58×
Q1 25
1.05×
Q4 24
Q3 24
1.00×
Q2 24
0.37×
Q1 24
5.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons